Search Results 541-550 of 17009 for EPOC
The Roberts Hepatobiliary Cancer Lab at Mayo Clinic is studying biomarkers for early detection of hepatocellular carcinoma and survival prediction.
Cediranib maleate and selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may also stop the ...
About this study. The purpose of this study is to evaluate new and complementary analytical MS technologies to identify and define the metabolic biomarkers ...
The purpose of this study is to determine if 3D volumetric measurements will allow more robust quantification of valvular heart disease severity. Participation ...
Current research projects include studies to find out if ECT can help treat severe agitation in people who have Alzheimer's dementia. Another study includes ...
Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling ...
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...
The purpose of this study is to evaluate the effects of RT234 on exercise parameters assessed by a specialized exercise test (Cardiopulmonary Exercise Test or ...
About this study. We are testing this hypothesis through three phases for which we have developed three protocols. In this phase, with this protocol, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!